Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target (Experimental & Molecular Medicine, (2019), 51, 12, (1-11), 10.1038/s12276-019-0351-y)

Research output: Contribution to journalComment/debate

Abstract

After online publication of this article, the authors noticed an error in the Acknowledgments section. The correct statement in this article should have read as follows. “The biospecimens for this study were provided by the Samsung Medical Center BioBank. This research was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3418); the National Research Foundation funded by the Ministry of Science, ICT and Future Planning (MSIP) of Korea (NRF-2015M3C9A1044522 and NRF-2018R1C1B3001648); and the intramural research fund of Ajou University Medical Center (2018).” The authors apologize for any inconvenience caused.

Original languageEnglish
Pages (from-to)1869
Number of pages1
JournalExperimental and Molecular Medicine
Volume52
Issue number11
DOIs
StatePublished - Nov 2020

Fingerprint

Dive into the research topics of 'Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target (Experimental & Molecular Medicine, (2019), 51, 12, (1-11), 10.1038/s12276-019-0351-y)'. Together they form a unique fingerprint.

Cite this